Results 241 to 250 of about 368,340 (301)

Successful Percutaneous Coronary Stenting in End-Stage Liver Disease Patients Awaiting Liver Transplantation. [PDF]

Cureus
Raza A, Lim P, Shah K, Sudyn A, Gerula C, Waller AH, Gardin JM, Klapholz M.   +7 more
europepmc   +1 more source

AI‐Powered Framework for Evaluating Drug Efficacy for Three‐Dimensional In Vitro Cancer Models in Robot‐Assisted Production

Advanced Robotics Research, EarlyView.
An AI‐powered, robot‐assisted framework automatically produces, images, and analyzes 3D tumor spheroids to evaluate drug efficacy. Integrated modules handle spheroid formation, live/dead staining, brightfield imaging, and automated image analysis, including spheroid segmentation, viability and metrics to assess the drug treatment efficacy. The workflow
Dalia Mahdy, Jesus Nieves, Lukas Königer, Matthias Peindl, Fabio Erhard, Marc Möllmann, Anke Klingner, Markus Münig, Bibin Babu, Thomas Schwarz, Marco Metzger, Gudrun Dandekar, Maximiliane Wußmann, Jan Hansmann   +13 more
wiley   +1 more source

Association of HLA-DQA1*06:01 and DPB1*05:01:01G alleles with susceptibility to end-stage liver disease with HBV infection in liver transplant recipients from the Zhejiang Han population, China. [PDF]

Front Immunol
Lu G, He Y, Lu Y, Chen W, Lu C, Zhu F.
europepmc   +1 more source

Palliative care for end-stage liver disease and acute on chronic liver failure: A systematic review. [PDF]

World J Methodol
Mafi VIP, Soldera J.
europepmc   +1 more source

Evaluation of the prognosis of hepatitis B virus-associated acute-on-chronic liver failure patients using a combined model for end-stage liver disease score with blood ammonia, lactate dehydrogenase, aspartate aminotransferase, and alanine aminotransferase. [PDF]

Medicine (Baltimore)
Wang Y, Chen L, Sun W, Li W, Xu Y, Gu J, Gan J.   +6 more
europepmc   +1 more source

Physiology and health assessment, risk balance, and model for end-stage liver disease scores: Postoperative outcome of liver transplantation. [PDF]

World J Transplant
Hohenreuther R, Silveira AT, Filho EMR, Garcez A, Lacerda BG, Fernandes SA, Marroni CA.   +6 more
europepmc   +1 more source

Complications of end-stage liver disease.

Canadian family physician Medecin de famille canadien, 2016
Giulia-Anna, Perri, Houman, Khosravani
openaire   +1 more source

Prognostic value of the modified Model for End-Stage Liver Disease score in patients treated with cardiac resynchronization therapy. [PDF]

Heart Rhythm O2
Long T, Yu Y, Cheng S, Huang H, Hua W.
europepmc   +1 more source

Prognostic models in end stage liver disease

Best Practice & Research Clinical Gastroenterology, 2023
Cirrhosis is a major cause of death worldwide, and is associated with significant health care costs. Even if milestones have been recently reached in understanding and managing end-stage liver disease (ESLD), the disease course remains somewhat difficult to prognosticate.
Ferrarese, A, Bucci, M, Zanetto, A, Senzolo, M, Germani, G, Gambato, M, Russo, F P, Burra, P   +7 more
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

End-stage liver disease complications

Current Opinion in Gastroenterology, 2013
Chronic liver disease causes significant morbidity and mortality because of any number of complications including hepatic encephalopathy, ascites, hepatorenal syndrome (HRS), and esophageal variceal hemorrhage (EVH).Predictors of response to lactulose, probiotics, and L-ornithine-L-aspartate therapy in minimal hepatic encephalopathy (MHE) have been ...
Robert S, Rahimi, Don C, Rockey
openaire   +2 more sources